Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 54.88% is in line with its 5-year average of 57.26%, around the middle of its 5-year range (45.92%–64.21%).
1.32% above its 12-month average of 54.17%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 55.60%.
GROSS MARGIN
54.88%
GROSS MARGIN AVG TTM
54.17%
GROSS MARGIN AVG 3Y
54.21%
GROSS MARGIN AVG 5Y
57.26%
GROSS MARGIN AVG 10Y
59.91%
GROSS MARGIN AVG 15Y
60.90%
GROSS MARGIN AVG 20Y
58.29%
CURRENT VS TTM AVG
+1.32%
CURRENT VS 3Y AVG
+1.24%
CURRENT VS 5Y AVG
-4.16%
CURRENT VS 10Y AVG
-8.40%
CURRENT VS 15Y AVG
-9.88%
CURRENT VS 20Y AVG
-5.85%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+32.62%
vs the sector median at left
Utah Medical Products, Inc.
Market Cap
$235.08M
Gross Margin
54.88%
TTM Avg
54.17%
3Y Avg
54.21%
5Y Avg
57.26%
Market Cap
$235.66M
Gross Margin
79.48%
TTM Avg
71.93%
3Y Avg
74.52%
5Y Avg
72.98%
Market Cap
$235.97M
Gross Margin
68.57%
TTM Avg
73.00%
3Y Avg
80.96%
5Y Avg
81.80%
Market Cap
$236.82M
Gross Margin
99.39%
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
25.00%
Market Cap
$232.72M
Gross Margin
-24677.94%
TTM Avg
-13289.35%
3Y Avg
-6830.59%
5Y Avg
-4553.73%
Market Cap
$231.77M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$231.37M
Gross Margin
71.12%
TTM Avg
81.41%
3Y Avg
85.88%
5Y Avg
90.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Utah Medical Products, Inc. (UTMD) | $235.08M | 54.88% | 54.17% | 54.21% | 57.26% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 79.48% | 71.93% | 74.52% | 72.98% |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | 68.57% | 73.00% | 80.96% | 81.80% |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | 99.39% | 50.00% | 25.00% | 25.00% |
| InflaRx N.V. (IFRX)vs › | $232.72M | -24677.94% | -13289.35% | -6830.59% | -4553.73% |
| Invivyd, Inc. (IVVD)vs › | $237.57M | 91.35% | 93.31% | 46.66% | 31.10% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | 71.12% | 81.41% | 85.88% | 90.00% |
| High Tide Inc. (HITI)vs › | $239.01M | 25.85% | 26.57% | 27.09% | 30.11% |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | 88.00% | 94.00% | 97.00% | 64.67% |
Gross Margin
54.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 55.60% |
| 2026-03-31 | 60.56% |
| 2025-12-31 | 52.31% |
| 2025-09-30 | 51.57% |
| 2025-06-30 | 50.80% |
| 2025-03-31 | 57.03% |
| 2024-12-31 | 58.12% |
| 2024-09-30 | 52.74% |
| 2024-06-30 | 55.22% |
| 2024-03-31 | 59.66% |
| 2023-12-31 | 57.55% |
| 2023-09-30 | 45.92% |
| 2023-06-30 | 47.63% |
| 2023-03-31 | 62.64% |
| 2022-12-31 | 61.35% |
| 2022-09-30 | 63.19% |
| 2022-06-30 | 60.70% |
| 2022-03-31 | 61.13% |
| 2021-12-31 | 62.82% |
| 2021-09-30 | 64.21% |
| 2021-06-30 | 61.77% |
| 2021-03-31 | 48.18% |
| 2020-12-31 | 60.49% |
| 2020-09-30 | 62.00% |
| 2020-06-30 | 56.33% |
| 2020-03-31 | 62.70% |
| 2019-12-31 | 66.05% |
| 2019-09-30 | 59.06% |
| 2019-06-30 | 63.31% |
| 2019-03-31 | 63.11% |
| 2018-12-31 | 62.59% |
| 2018-09-30 | 60.58% |
| 2018-06-30 | 63.69% |
| 2018-03-31 | 63.58% |
| 2017-12-31 | 63.43% |
| 2017-09-30 | 64.16% |
| 2017-06-30 | 63.65% |
| 2017-03-31 | 63.70% |
| 2016-12-31 | 61.46% |
| 2016-09-30 | 59.81% |
| 2016-06-30 | 59.60% |
| 2016-03-31 | 60.41% |
| 2015-12-31 | 61.52% |
| 2015-09-30 | 61.13% |
| 2015-06-30 | 58.66% |
| 2015-03-31 | 59.73% |
| 2014-12-31 | 62.36% |
| 2014-09-30 | 57.81% |
| 2014-06-30 | 60.52% |
| 2014-03-31 | 61.57% |
| 2013-12-31 | 59.43% |
| 2013-09-30 | 59.30% |
| 2013-06-30 | 60.47% |
| 2013-03-31 | 60.55% |
| 2012-12-31 | 61.23% |
| 2012-09-30 | 61.75% |
| 2012-06-30 | 60.56% |
| 2012-03-31 | 60.14% |
| 2011-12-31 | 59.68% |
| 2011-09-30 | 60.44% |
| 2011-06-30 | 60.33% |
| 2011-03-31 | 54.62% |
| 2010-12-31 | 52.91% |
| 2010-09-30 | 53.80% |
| 2010-06-30 | 52.06% |
| 2010-03-31 | 51.63% |
| 2009-12-31 | 53.20% |
| 2009-09-30 | 52.45% |
| 2009-06-30 | 52.89% |
| 2009-03-31 | 54.31% |
| 2008-12-31 | 51.71% |
| 2008-09-30 | 54.83% |
| 2008-06-30 | 55.11% |
| 2008-03-31 | 54.44% |
| 2007-12-31 | 54.73% |
| 2007-09-30 | 55.98% |
| 2007-06-30 | 55.55% |
| 2007-03-31 | 55.31% |
| 2006-12-31 | 55.64% |
| 2006-09-30 | 56.72% |
| 2006-06-30 | 55.90% |
| 2006-03-31 | 56.40% |
| 2005-12-31 | 56.81% |
| 2005-09-30 | 57.33% |
| 2005-06-30 | 57.23% |
| 2005-03-31 | 56.13% |
| 2004-12-31 | 54.97% |
| 2004-09-30 | 56.66% |
| 2004-06-30 | 57.62% |
| 2004-03-31 | 58.19% |
| 2003-12-31 | 58.60% |
| 2003-09-30 | 58.85% |
| 2003-06-30 | 58.96% |
| 2003-03-31 | 57.83% |
| 2002-12-31 | 57.67% |
| 2002-09-30 | 58.23% |